Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Feb 21, 2025; 31(7): 98448
Published online Feb 21, 2025. doi: 10.3748/wjg.v31.i7.98448
Figure 4
Figure 4 The ability of infliximab, ustekinumab, and vedolizumab to achieve endoscopic outcomes in patients with isolated proximal small bowel Crohn’s disease after 1 year of therapy. A: Complete; B: Jejunum; C: Proximal ileum. aP < 0.05.